Kim, P.J., Plescia, J., Clevers, H., Fearon, E.R. and Altieri, D.C. (2003) Survivin and Molecular Pathogenesis of Colorectal Cancer. The Lancet, 362, 205-209.
has been cited by the following article:
TITLE: A Review on Survivin as a Prognostic and Therapeutic Cancer Biomarker
AUTHORS: Amal Ahmed Ismail
KEYWORDS: Survivin, Prognostic Biomarker, Cancer, Antiapoptotic
JOURNAL NAME: Open Journal of Pathology, Vol.8 No.1, December 29, 2017
ABSTRACT: Survivin is an antiapoptotic protein expressed in tumor cells that correlates with aggressiveness, prognosis and treatment. Objective: This review summarizes significance of survivin expression among different tumor types highlighting the potential value of survivin as an important biomarker that may have an impact on patient’s response to therapy with prognostic implications.